AI-Driven Drug Discovery and Development

Abstract

Artificial intelligence (AI) has revolutionized the discovery and development of new drugs in biomedicine. By using advanced algorithms and computational methods, AI optimizes treatment plans, accelerates the drug development process, and improves patient outcomes. AI algorithms integrate multi-omics data sets, decipher molecular connections, and identify therapeutic targets and biomarkers. High-throughput screening, predictive modeling, and AI-powered virtual screening platforms are revolutionizing the drug development pipeline. Machine learning and deep learning models enable drug-target interactions prediction, pharmacological evaluation, and experimental validation. Structure-based drug design methodologies accelerate the discovery of new therapies. AI-driven technologies enable personalized treatment plans for patients, taking into account their unique traits and disease profiles. Pharmacogenomics, when combined with predictive analytics, improves drug selection, dosage adjustment, and treatment response prediction, enhancing therapeutic efficacy and reducing side effects.